Human Recombinant Antibodies against Plasmodium falciparum Merozoite Surface Protein 3 Cloned from Peripheral Blood Leukocytes of Individuals with Immunity to Malaria Demonstrate Antiparasitic Properties

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Infection and Immunity

• Publication date

  2006-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.00928-05PMID 16714549PMCID PMC1479282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterisation of two novel proteins from the asexual stage of Plasmodium falciparum, H101 and H103.

  2005cited by this paper
• Academic Editor: Brian Greenwood, University of London, United Kingdom

  2005cited by this paper
• Dissection of Merozoite Surface Protein 3, a Representative of a Family of Plasmodium falciparum Surface Proteins, Reveals an Oligomeric and Highly Elongated Molecule*

  2005cited by this paper
• Phase I Malaria Vaccine Trial with a Long Synthetic Peptide Derived from the Merozoite Surface Protein 3 Antigen

  2005cited by this paper
• Plasmodium falciparum Merozoite Surface Protein 6 Displays Multiple Targets for Naturally Occurring Antibodies That Mediate Monocyte-Dependent Parasite Killing

  2005cited by this paper
• Relationships between the outcome of Plasmodium falciparum infection and the intensity of transmission in Africa.

  2004cited by this paper
• The alanine-rich heptad repeats are intact in the processed form of Plasmodium falciparum MSP3.

  2004cited by this paper
• Association between Protection against Clinical Malaria and Antibodies to Merozoite Surface Antigens in an Area of Hyperendemicity in Myanmar: Complementarity between Responses to Merozoite Surface Protein 3 and the 220-Kilodalton Glutamate-Rich Protein

  2004cited by this paper
• Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design.

  2004cited by this paper
• Plasmodium falciparum: production of human antibodies specific for the MSP-3 protein in the Hu-SPL-SCID mouse.

  2004cited by this paper
• Fcγ receptor‐mediated phagocytosis of Plasmodium falciparum‐infected erythrocytes in vitro

  2002cited by this paper
• Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys.

  2002cited by this paper
• Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2

  2002cited by this paper
• Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project.

  2001cited by this paper
• Premunition against Plasmodium falciparum in a malaria hyperendemic village in Myanmar.

  2001cited by this paper
• The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex.

  2001cited by this paper
• Differential Patterns of Human Immunoglobulin G Subclass Responses to Distinct Regions of a Single Protein, the Merozoite Surface Protein 1 of Plasmodium falciparum

  2001cited by this paper
• Isolation of a monoclonal antibody from a malaria patient-derived phage display library recognising the Block 2 region of Plasmodium falciparum merozoite surface protein-1.

  2001cited by this paper
• Selection of Glutamate-Rich Protein Long Synthetic Peptides for Vaccine Development: Antigenicity and Relationship with Clinical Protection and Immunogenicity

  2001cited by this paper
• Recombinant Human Antibodies Specific for the Pfs48/45 Protein of the Malaria Parasite Plasmodium falciparum *

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.

  2000cited by this paper
• Cytophilic Immunoglobulin Responses to Plasmodium falciparum Glutamate-Rich Protein Are Correlated with Protection against Clinical Malaria in Dielmo, Senegal

  2000cited by this paper
• Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry.

  1999cited by this paper
• Structural Requirements of the Major Protective Antibody to Haemophilus influenzae Type b

  1999cited by this paper
• Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites.

  1999cited by this paper
• Monocytes.

  1998cited by this paper
• Stochastic modeling and optimization of phage display.

  1998cited by this paper
• IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.

  1998cited by this paper
• An alternative to serum for cultivation of Plasmodium falciparum in vitro.

  1997cited by this paper
• Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells.

  1997influential reference
• Phage-display libraries of murine and human antibody Fab fragments

  1996cited by this paper
• Use of hydroethidine and flow cytometry to assess the effects of leukocytes on the malarial parasite Plasmodium falciparum

  1995cited by this paper
• Solution structure of a polypeptide containing four heptad repeat units from a merozoite surface antigen of Plasmodium falciparum.

  1995cited by this paper
• Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages

  1995influential reference
• Phage display used for gene cloning of human recombinant antibody against the erythrocyte surface antigen, rhesus D.

  1995influential reference
• Analysis of binding of monoclonal antibody to a malarial peptide by surface plasmon resonance biosensor and integrated rate equations.

  1994cited by this paper
• Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites.

  1994influential reference
• Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes.

  1994influential reference
• Efficient method for constructing comprehensive murine Fab antibody libraries displayed on phage.

  1993cited by this paper
• A vector for the removal of deletion mutants from antibody libraries.

  1992cited by this paper
• Recombinant Plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay.

  1991cited by this paper
• 6 Allotypes and other epitopes of immunoglobulins

  1991cited by this paper
• Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.

  1991cited by this paper
• Allotypes and other epitopes of immunoglobulins.

  1991influential reference
• Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

  1990influential reference
• Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status

  1987cited by this paper
• Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum

  1983cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979influential reference
• Nucleotide sequence of bacteriophage φX174 DNA

  1977cited by this paper
• Nucleotide sequence of bacteriophage phi X174 DNA.

  1977cited by this paper
• THE PASSIVE TRANSFER OF HUMAN MALARIAL IMMUNITY.

  1964cited by this paper
• ADULT AND CORD-BLOOD GAMMA-GLOBULIN AND IMMUNITY TO MALARIA IN NIGERIANS

  1962cited by this paper
• Gamma-Globulin and Acquired Immunity to Human Malaria

  1961cited by this paper

• Host-parasite interactions during Plasmodium infection: Implications for immunotherapies

  2023cites this paper
• Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy

  2021influential citation
• Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein

  2019cites this paper
• Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria

  2017cites this paper
• Merozoite surface protein-1 from P. falciparum is a major target of opsonizing antibodies in individuals with acquired immunity against malaria

  2017cites this paper
• Anticorpos contra a proteína de ligação em Duffy (PvDBP) e proteção contra a malária vivax na Amazônia rural brasileira.

  2017cites this paper
• Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display

  2016influential citation
• Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1

  2016cites this paper
• [IgG responses to candidate malaria vaccine antigens in the urban area of Dakar (Senegal): evolution according to age and parasitemia in patients with mild symptoms].

  2015cites this paper
• Isolation, production and characterization of fully human monoclonal antibodies directed to Plasmodium falciparum MSP10

  2015cites this paper
• Generierung Plasmodium falciparum-spezifischer humaner Antikörperformate aus Epstein-Barr Virus-transformierten B Lymphozyten semi-immuner Individuen

  2015cites this paper
• Establishment of a phage display platform for the isolation of plasmodium falciparum specific monoclonal antibodies

  2015cites this paper
• Analyses des réponses IgG dirigées contre des antigènes candidats vaccins dans le paludisme urbain non aggravé à Dakar (Sénégal) : variations suivant l’âge et les densités parasitaires

  2015cites this paper
• Principles and application of antibody libraries for infectious diseases

  2014cites this paper
• Assessment of antibody-dependent respiratory burst activity from mouse neutrophils on Plasmodium yoelii malaria challenge outcome

  2014cites this paper
• The GPI-anchored 6-Cys protein Pv12 is present in detergent-resistant microdomains of Plasmodium vivax blood stage schizonts.

  2013cites this paper
• Maternofetal transplacental transport of recombinant IgG antibodies lacking effector functions.

  2013influential citation
• Progress and Challenges towards the Development of Malaria Vaccines

  2012cites this paper
• Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro

  2012cites this paper
• Antibodies against the Plasmodium falciparum glutamate-rich protein from naturally exposed individuals living in a Brazilian malaria-endemic area can inhibit in vitro parasite growth.

  2011cites this paper
• Human recombinant antibodies against Trypanosoma cruzi ribosomal P2β protein

  2011cites this paper
• Chapter 65 – Malaria

  2009cites this paper
• Isolation and expression of UB05, a Plasmodium falciparum antigen recognised by antibodies from semi-immune adults in a high transmission endemic area of the Cameroonian rainforest

  2009cites this paper
• Identification of Plasmodium Falciparum proteins interacting with the erythrocyte membrane skeleton protein spectrin

  2009cites this paper
• Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus

  2009cites this paper
• Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.

  2008cites this paper
• Immune responses to polymorphic antigens and protection against severe malaria in Kenyan children

  2008cites this paper
• Malaria vaccines: into a mirror, darkly?

  2008influential citation
• Modification of a human monoclonal antibody Fab fragment specific for Plasmodium falciparum 19-kDa C-terminal merozoite surface protein 1 by site-directed mutagenesis

  2008influential citation
• Malaria vaccines: immunity, models and monoclonal antibodies.

  2008cites this paper
• Phage display: a useful tool for malaria research?

  2008cites this paper
• Single-Chain Antibody Fragment Specific for Plasmodium vivax Duffy Binding Protein (cid:1)

  2007cites this paper
• Single-Chain Antibody Fragment Specific for Plasmodium vivax Duffy Binding Protein

  2007cites this paper
• A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes FcγRII and FcγRIII1

  2007cites this paper
• Production of High-Affinity Human Monoclonal Antibody Fab Fragments to the 19-Kilodalton C-Terminal Merozoite Surface Protein 1 of Plasmodium falciparum

  2007cites this paper
• Functional in vitro studies of recombinant human immunoglobulin G and immunoglobulin A anti‐D

  2007cites this paper
• Long-Term Clinical Protection from Falciparum Malaria Is Strongly Associated with IgG3 Antibodies to Merozoite Surface Protein 3

  2007cites this paper
• The Importance of Human FcγRI in Mediating Protection to Malaria

  2007cites this paper
• Paediatric and neonatal infections 237 Adverse events following immunization: perception and evidence.

  2007cites this paper
• Survey of the year 2003 commercial optical biosensor literature

  2005cites this paper